Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Goodwill (2017 - 2025)

Historic Goodwill for Ultragenyx Pharmaceutical (RARE) over the last 9 years, with Q3 2025 value amounting to $44.4 million.

  • Ultragenyx Pharmaceutical's Goodwill changed 0.0% to $44.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $44.4 million for FY2024, which is 0.0% changed from last year.
  • Ultragenyx Pharmaceutical's Goodwill amounted to $44.4 million in Q3 2025, which was down 0.0% from $44.4 million recorded in Q2 2025.
  • Ultragenyx Pharmaceutical's 5-year Goodwill high stood at $44.4 million for Q1 2021, and its period low was $44.4 million during Q1 2021.
  • Moreover, its 5-year median value for Goodwill was $44.4 million (2021), whereas its average is $44.4 million.
  • Data for Ultragenyx Pharmaceutical's Goodwill shows a peak YoY increase of 0.0% (in 2021) and a maximum YoY decrease of 0.0% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Ultragenyx Pharmaceutical's Goodwill stood at $44.4 million in 2021, then changed by 0.0% to $44.4 million in 2022, then changed by 0.0% to $44.4 million in 2023, then changed by 0.0% to $44.4 million in 2024, then changed by 0.0% to $44.4 million in 2025.
  • Its Goodwill stands at $44.4 million for Q3 2025, versus $44.4 million for Q2 2025 and $44.4 million for Q1 2025.